Pharmalittle: FDA push for trial transparency, Novo-OpenAI deal
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
Pharmalittle: Novo boosts consumer focus, FDA okays gene therapy
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
Pharmalittle: We’re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…